1.Multicompartmental congenital intracranial immature teratoma
Dharmendra Ganesan ; Sheau Fung Sia ; Vairavan Narayanan ; Gnana Kumar ; Lucy Lum ; Lucy Chan ; KS Mun ; Vicknes Waran
Neurology Asia 2013;18(1):117-121
Congenital intracranial tumors are rare and account for 0.5 to 1.5% of all childhood tumours. We report
a case of a 3 week old baby presenting with multi compartmental congenital intracranial immature
teratoma, fi rst of its kind in the literature. The child had gross total excision in two stages with aid of
neuronavigation. The short term outcome was good. The four years of follow-up with serial imaging
showed no tumour recurrence with a stable hydrocephalus after shunting. However, there is global
developmental delay with full time dependence of care giver
2.Level 4 comprehensive epilepsy program in Malaysia, a resource-limited country
Kheng-Seang LIM ; Sherrini Ahmad Bazir Ahmad ; Vairavan NARAYANAN ; Kartini RAHMAT ; Norlisah Mohd RAMLI ; Kein-Seong MUN ; Kum-Thong WONG ; Noraini ISMAIL ; Shweh-Fern LOO ; Chong-Tin TAN
Neurology Asia 2017;22(4):299-305
Background and Objective: There is a great challenge to establish a level 4 epilepsy care offeringcomplete evaluation for epilepsy surgery including invasive monitoring in a resource-limited country.This study aimed to report the setup of a level 4 comprehensive epilepsy program in Malaysia and theoutcome of epilepsy surgery over the past 4 years. Methods: This is a retrospective study analyzingcases with intractable epilepsy in a comprehensive epilepsy program in University Malaya MedicalCenter (UMMC), Kuala Lumpur, from January 2012 to August 2016. Results: A total of 92 caseshad comprehensive epilepsy evaluation from January 2012 till August 2016. The mean age was 35.57years old (range 15-59) and 54 (58.7%) were male. There were 17 cases having epilepsy surgeryafter stage-1 evaluation. Eleven cases had mesial temporal sclerosis and 81% achieved Engel classI surgical outcome. Six cases had lesionectomy and 60% had Engel class I outcome. A total of 16surgeries were performed after stage-2 evaluation, including invasive EEG monitoring in 9 cases.Among those with surgery performed more than 12 months from the time of data collection, 5/10(50%) achieved Engel I outcome, whereas 2 (20%) had worthwhile improvement (Engel class III)with 75% and 90% seizure reduction.Conclusion: Level 4 epilepsy care has an important role and is possible with joint multidisciplinaryeffort in a middle-income country like Malaysia despite resource limitation.